AVH News: AVITA Medical, Inc. (ASX:AVH) Could Be Riskier Than It Looks - 5th May 2023, 11:40am

[annb0t]

It's not a stretch to say that AVITA Medical, Inc.'s (ASX:AVH) price-to-sales (or "P/S") ratio of 12.3x right now seems quite "middle-of-the-road" for companies in the Biotechs industry in Australia, where the median P/S ratio is around 13.8x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.

View our latest analysis for AVITA Medical ps-multiple-vs-industry

How Has AVITA Medical Performed Recently?

AVITA Medical coul...

>>> Read more: AVITA Medical, Inc. (ASX:AVH) Could Be Riskier Than It Looks